|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7800 HKD | -1.27% |
|
-4.88% | +39.29% |
| Capitalization | 59Cr 67Cr 8.6Cr 7.41Cr 6.78Cr 6.41Cr 12Cr 829.68Cr 12Cr 81Cr 31Cr 391.73Cr 32Cr 32Cr 1.37TCr | P/E ratio 2024 |
8.46x | P/E ratio 2025 | 25.2x |
|---|---|---|---|---|---|
| Enterprise value | 52Cr 59Cr 7.58Cr 6.54Cr 5.98Cr 5.66Cr 10Cr 732.08Cr 11Cr 71Cr 28Cr 345.64Cr 28Cr 28Cr 1.21TCr | EV / Sales 2024 |
0.36x | EV / Sales 2025 | 0.21x |
| Free-Float |
24.24% | Yield 2024 |
5.05% | Yield 2025 | - |
| 1 day | -1.27% | ||
| 1 week | -4.88% | ||
| Current month | -3.70% | ||
| 1 month | -9.30% | ||
| 3 months | +6.85% | ||
| 6 months | +32.20% | ||
| Current year | +39.29% |
| 1 week | 0.77 |  | 0.82 |
| 1 month | 0.77 | | 0.9 |
| Current year | 0.54 | | 0.98 |
| 1 year | 0.5 | | 0.98 |
| 3 years | 0.5 | | 1.56 |
| 5 years | 0.5 | | 1.66 |
| 10 years | 0.5 | | 2.43 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ying Feng Lai
CEO | Chief Executive Officer | 34 | 24/03/2021 |
Ying Sheng Lai
DFI | Director of Finance/CFO | 32 | 24/03/2021 |
Wing Yan Ho
SEC | Corporate Secretary | 44 | 05/05/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Kwun Wan Ng
BRD | Director/Board Member | 62 | 08/06/2015 |
Zhi Tian Lai
CHM | Chairman | 59 | 12/09/2014 |
Li Xia Jiang
BRD | Director/Board Member | 61 | 12/09/2014 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.27% | -4.88% | -15.22% | -27.78% | 8.71Cr | |
| -1.23% | +0.51% | +8.50% | +102.47% | 4.75TCr | |
| -0.49% | +1.23% | +68.25% | +127.13% | 3.71TCr | |
| -1.15% | +8.04% | -6.01% | +54.16% | 1.2TCr | |
| +2.80% | +6.47% | +12.87% | +100.55% | 1.04TCr | |
| +1.22% | -0.80% | +35.33% | +120.35% | 910.11Cr | |
| -0.68% | -1.50% | +59.91% | -6.52% | 722.14Cr | |
| -0.56% | -1.75% | +17.01% | +52.84% | 732.4Cr | |
| +2.82% | +2.50% | +66.08% | +298.26% | 685.44Cr | |
| -2.14% | -10.74% | +146.96% | +471.09% | 580.39Cr | |
| Average | -0.07% | +0.33% | +39.37% | +129.26% | 1.43TCr | |
| Weighted average by Cap. | -0.37% | +1.68% | +36.15% | +122.01% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 221.48Cr 254.6Cr 33Cr 28Cr 26Cr 24Cr 45Cr 3.14TCr 46Cr 305.66Cr 118.92Cr 1.48TCr 121.97Cr 119.38Cr 5.17TCr | 173.75Cr 199.73Cr 25Cr 22Cr 20Cr 19Cr 35Cr 2.46TCr 36Cr 239.79Cr 93Cr 1.16TCr 96Cr 94Cr 4.06TCr |
| Net income | 9.52Cr 11Cr 1.4Cr 1.2Cr 1.1Cr 1.04Cr 1.92Cr 134.87Cr 1.97Cr 13Cr 5.11Cr 64Cr 5.24Cr 5.13Cr 222.21Cr | 1.73Cr 1.99Cr 25.37L 21.87L 20.02L 18.93L 34.89L 24Cr 35.71L 2.39Cr 92.83L 12Cr 95.22L 93.19L 40Cr |
| Net Debt | -1.11Cr -1.27Cr -16.27L -14.02L -12.84L -12.14L -22.38L -16Cr -22.9L -1.53Cr -59.53L -7.42Cr -61.06L -59.76L -26Cr | -6.89Cr -7.92Cr -1.01Cr -87.14L -79.77L -75.43L -1.39Cr -98Cr -1.42Cr -9.51Cr -3.7Cr -46Cr -3.79Cr -3.71Cr -160.82Cr |
Employees
2,284
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/26/19 | 0.7800 $ | -1.27% | 4,20,000 |
| 18/26/18 | 0.7900 $ | +1.28% | 3,53,000 |
| 15/26/15 | 0.7800 $ | -2.50% | 3,64,000 |
| 14/26/14 | 0.8000 $ | -1.23% | 3,39,000 |
| 13/26/13 | 0.8100 $ | -1.22% | 4,69,000 |
- Stock Market
- Equities
- 3737 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition